95 related articles for article (PubMed ID: 25283264)
1. Design, synthesis and pharmacological evaluation of novel NO-releasing benzimidazole hybrids as potential antihypertensive candidate.
Zhang Y; Xu J; Li Y; Yao H; Wu X
Chem Biol Drug Des; 2015 May; 85(5):541-8. PubMed ID: 25283264
[TBL] [Abstract][Full Text] [Related]
2. Novel nitric oxide-releasing isochroman-4-one derivatives: Synthesis and evaluation of antihypertensive activity.
Bai R; Yang X; Zhu Y; Zhou Z; Xie W; Yao H; Jiang J; Liu J; Shen M; Wu X; Xu J
Bioorg Med Chem; 2012 Dec; 20(23):6848-55. PubMed ID: 23084434
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.
Kaur N; Kaur A; Bansal Y; Shah DI; Bansal G; Singh M
Bioorg Med Chem; 2008 Dec; 16(24):10210-5. PubMed ID: 19013821
[TBL] [Abstract][Full Text] [Related]
5. WB1106, a novel nitric oxide-releasing derivative of telmisartan, inhibits hypertension and improves glucose metabolism in rats.
Li YQ; Ji H; Zhang YH; Shi WB; Meng ZK; Chen XY; Du GT; Tian J
Eur J Pharmacol; 2007 Dec; 577(1-3):100-8. PubMed ID: 17822696
[TBL] [Abstract][Full Text] [Related]
6. Apocynum venetum leaf extract, an antihypertensive herb, inhibits rat aortic contraction induced by angiotensin II: a nitric oxide and superoxide connection.
Lau YS; Kwan CY; Ku TC; Hsieh WT; Wang HD; Nishibe S; Dharmani M; Mustafa MR
J Ethnopharmacol; 2012 Sep; 143(2):565-71. PubMed ID: 22835814
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and pharmacological evaluation of 5-oxo-1,2,4-oxadiazole derivatives as AT1 antagonists with antihypertension activities.
Zhu W; Bao X; Ren H; Liao P; Zhu W; Yan Y; Wang L; Chen Z
Clin Exp Hypertens; 2016; 38(5):435-42. PubMed ID: 27362285
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
Inada Y; Wada T; Shibouta Y; Ojima M; Sanada T; Ohtsuki K; Itoh K; Kubo K; Kohara Y; Naka T
J Pharmacol Exp Ther; 1994 Mar; 268(3):1540-7. PubMed ID: 8138966
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities.
Zhu W; Da Y; Wu D; Zheng H; Zhu L; Wang L; Yan Y; Chen Z
Bioorg Med Chem; 2014 Apr; 22(7):2294-302. PubMed ID: 24613628
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring.
Guo XZ; Shi L; Wang R; Liu XX; Li BG; Lu XX
Bioorg Med Chem; 2008 Dec; 16(24):10301-10. PubMed ID: 18976926
[TBL] [Abstract][Full Text] [Related]
12. New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers.
García G; Serrano I; Sánchez-Alonso P; Rodríguez-Puyol M; Alajarín R; Griera M; Vaquero JJ; Rodríguez-Puyol D; Alvarez-Builla J; Díez-Marqués ML
Eur J Med Chem; 2012 Apr; 50():90-101. PubMed ID: 22336384
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center.
Han XF; He X; Wang M; Xu D; Hao LP; Liang AH; Zhang J; Zhou ZM
Eur J Med Chem; 2015 Oct; 103():473-87. PubMed ID: 26397395
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
16. New NO-releasing pharmacodynamic hybrids of losartan and its active metabolite: design, synthesis, and biopharmacological properties.
Breschi MC; Calderone V; Digiacomo M; Macchia M; Martelli A; Martinotti E; Minutolo F; Rapposelli S; Rossello A; Testai L; Balsamo A
J Med Chem; 2006 Apr; 49(8):2628-39. PubMed ID: 16610806
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the NO-releasing properties of NO-donor linkers.
Calderone V; Digiacomo M; Martelli A; Minutolo F; Rapposelli S; Testai L; Balsamo A
J Pharm Pharmacol; 2008 Feb; 60(2):189-95. PubMed ID: 18237466
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of novel NO-releasing 4-chromanone derivatives as potential vasodilator agents.
Shi H; Xiong L; Zhu C; Wang J; Li Y; Luo Y; Wang T; Zhang C
Chem Biol Drug Des; 2023 Feb; 101(2):408-421. PubMed ID: 36054155
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
Bhandari SV; Bothara KG; Patil AA; Chitre TS; Sarkate AP; Gore ST; Dangre SC; Khachane CV
Bioorg Med Chem; 2009 Jan; 17(1):390-400. PubMed ID: 19036593
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
Abbhi V; Saini L; Mishra S; Sethi G; Kumar AP; Piplani P
Bioorg Med Chem; 2017 Nov; 25(21):6071-6085. PubMed ID: 29033348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
